Načítá se...
GABA-ergic Cell Therapy for Epilepsy: Advances, Limitations and Challenges
Diminution in the number of gamma-amino butyric acid positive (GABA-ergic) interneurons and their axon terminals, and/or alterations in functional inhibition are conspicuous brain alterations believed to contribute to the persistence of seizures in acquired epilepsies such as temporal lobe epilepsy....
Uloženo v:
| Vydáno v: | Neurosci Biobehav Rev |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4869704/ https://ncbi.nlm.nih.gov/pubmed/26748379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neubiorev.2015.12.014 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|